U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Hydroxocobalamin Injection
Status: Currently in Shortage
»Date first posted: 11/04/2024
»Therapeutic Categories: Other

BTG International Inc. (Revised 02/07/2025)

Company Contact Information:
844-293-0007

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) Limited Availability Restrictions on supply of Cyanokit will continue through to Q2 2025 (estimated). To address the current drug shortage, BTG International Inc (a SERB Pharmaceuticals company) is coordinating with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.

Dear Healthcare Professional Letter (HYPERLINK)

Requirements related to complying with good manufacturing practices
Back to Top